Studies have shown that the knockdown or pharmacological inhibition of USP8 increases the sensitivity of colorectal cancer cells to ferroptosis and that USP8 interacts with GPX4 and prevents GPX4 protein degradation by affecting GPX4 deubiquitination [18]. Here, USP8 is linked to colorectal cancer.